Cough
📧 Sign up to get email alerts when something new happens for Cough.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-01-26Clinical Trial Update: Repeat Doses of BAY 1817080 in Healthy Males & Proof of Concept in Chronic Cough Patients [Phase 1, Phase 2]
Clinical trial update for BAY 1817080 including repeat dosing in healthy males and proof-of-concept in chronic cough patients (Phase 1/Phase…
-
CLINICAL_TRIALS trial_result · 2023-01-05Clinical Trial Update: Effects of Second-generation Antihistamine Bepotastine on Cough Outcomes in Cough Patients With Allergic Rhinitis [Phase 4]
Phase 4 trial update evaluating the effects of the second-generation antihistamine bepotastine on cough outcomes in patients with allergic r…
-
FDA approval · 2022-12-09FDA Approved: MUCUS RELIEF — Supplemental Application (CHAIN DRUG MARKETING ASSOCIATION, INC.)
FDA approved a supplemental application for MUCUS RELIEF, an over-the-counter guaifenesin product.
-
CLINICAL_TRIALS trial_result · 2022-11-08Clinical Trial Update: Randomized Placebo-controlled Analysis of Superior Laryngeal Nerve Block for Neurogenic Cough [Phase 3]
Phase 3 randomized placebo-controlled study investigating superior laryngeal nerve block for neurogenic cough.
-
CLINICAL_TRIALS trial_result · 2022-10-14Clinical Trial Update: Efficacy and Safety of Gefapixant (MK-7264) in Adult Participants With Recent Onset Chronic Cough (MK-7264-043) [Phase 3]
Phase 3 trial update for gefapixant (MK-7264) in adults with recent onset chronic cough; results posted after completion.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-09-19Clinical Trial Update: Kesuting Syrup in the Treatment of Corona Virus Disease 2019 (COVID-19) [Phase 4]
Phase 4 clinical trial update on Kesuting Syrup for COVID-19 pneumonia and cough has completed.
-
CLINICAL_TRIALS trial_result · 2022-08-19Clinical Trial Update: Stimulation With Wire Leads to Restore Cough [NA]
A completed clinical trial investigated stimulation with wire leads as a potential approach to restore coughing in individuals with spinal c…
-
CLINICAL_TRIALS trial_result · 2022-08-18Clinical Trial Update: Clinical Study to Evaluate the Efficacy and Safety of Three Different Doses of BAY1817080 Compared to Placebo in Patients With Chronic Cough [Phase 2]
Phase 2 trial evaluating three dose levels of BAY1817080 versus placebo in patients with chronic cough has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-06-16Clinical Trial Update: The Effects of Salbutamol on Mannitol Induced Cough Responses in Healthy Controls [Phase 2]
Phase 2 clinical trial evaluating the effects of salbutamol on cough responses induced by mannitol in healthy controls has been completed.
-
CLINICAL_TRIALS trial_result · 2022-04-26Clinical Trial Update: A Dose-ranging Study of Orvepitant in Patients With Chronic Refractory Cough [Phase 2]
Phase 2 dose-ranging study of Orvepitant in chronic refractory cough has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-02-14Clinical Trial Update: Effect of Magnesium on Remifentanil Induced Cough [Phase 4]
Phase 4 clinical trial examining whether magnesium reduces remifentanil-induced cough.
-
CLINICAL_TRIALS trial_result · 2021-12-13Clinical Trial Update: Evaluation of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough [Phase 2]
Phase 2 trial updating on efficacy and safety of BLU-5937 in adults with refractory chronic cough.
-
CLINICAL_TRIALS trial_result · 2021-11-01Clinical Trial Update: A Study of Gefapixant (MK-7264) in Japanese Adult Participants With Refractory or Unexplained Chronic Cough (MK-7264-038) [Phase 3]
Phase 3 trial evaluating gefapixant (MK-7264) for refractory or unexplained chronic cough in Japanese adults has completed and results poste…
-
FDA approval · 2021-09-27FDA Approved: HYCODAN — Supplemental Application (Genus Lifesciences Inc.)
The FDA granted a supplemental approval for HYCODAN, a hydrocodone bitartrate and homatropine methylbromide combination product from Genus L…
-
CLINICAL_TRIALS trial_result · 2021-09-02Clinical Trial Update: A Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-030) [Phase 3]
Phase 3 trial of gefapixant (MK-7264) in adults with chronic cough completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-08-03Clinical Trial Update: A Dose Escalation Study of BLU-5937 in Unexplained or Refractory Chronic Cough [Phase 2]
Phase 2 dose-escalation study of BLU-5937 in chronic refractory cough was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-06-16Clinical Trial Update: A Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-027) [Phase 3]
Phase 3 trial of gefapixant (MK-7264) in adults with chronic cough completed; results posted.
-
CLINICAL_TRIALS trial_result · 2021-05-26Clinical Trial Update: A Study of Gefapixant (AF-219/MK-7264) in Participants With Idiopathic Pulmonary Fibrosis (IPF) With Persistent Cough (MK-7264-016) [Phase 2]
Phase 2 study of Gefapixant (MK-7264) in idiopathic pulmonary fibrosis patients with persistent cough has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-04-28Clinical Trial Update: Dextromethorphan Pediatric Acute Cough Study [Phase 4]
Phase 4 pediatric acute cough study of dextromethorphan was terminated; results were posted.
-
CLINICAL_TRIALS trial_result · 2021-03-15Clinical Trial Update: BNO 1030 Extract (Imupret) in the Treatment of Mild Forms of COVID-19 [Phase 4]
Phase 4 trial assessing BNO 1030 Extract (Imupret) for mild COVID-19; study completed.
-
CLINICAL_TRIALS trial_result · 2021-02-12Clinical Trial Update: Effect of Gefapixant (AF-219/MK-7264) on Cough Reflex Sensitivity (MK-7264-015) [Phase 2]
Phase 2 trial evaluating the effect of gefapixant (MK-7264) on cough reflex sensitivity in refractory chronic cough has completed with poste…
-
CLINICAL_TRIALS trial_result · 2021-02-10Clinical Trial Update: Repeat Doses of BAY1902607 in Healthy Males and Proof of Concept in Chronic Cough Patients [Phase 1, Phase 2]
Clinical trial update reports repeat dosing of BAY1902607 in healthy males and a proof-of-concept in chronic cough patients across Phase 1 a…
-
CLINICAL_TRIALS trial_result · 2020-12-22Clinical Trial Update: Pilot of Zinc Acetate to Improve Chronic Cough [Phase 2]
Phase 2 pilot study investigating zinc acetate to improve chronic cough has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-11-02Clinical Trial Update: A Study to Assess the Efficacy of Gefapixant (MK-7264/AF-219), in Participants With Chronic Cough (MK-7264-006) [Phase 2]
Phase 2 trial evaluating gefapixant (MK-7264/AF-219) for chronic cough has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-10-22Clinical Trial Update: A Dose Escalation Study of Gefapixant (AF-219/MK-7264) in Refractory Chronic Cough (MK-7264-010) [Phase 2]
Phase 2 dose-escalation study of gefapixant (MK-7264) in refractory chronic cough completed; results posted in 2020.